These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 20986568)

  • 1. Notes on the pathogenesis of congenital hemolytic disease (erythroblastosis fetalis).
    WIENER AS
    Am J Clin Pathol; 1946 May; 16():319-21. PubMed ID: 20986568
    [No Abstract]   [Full Text] [Related]  

  • 2. Pathogenesis of congenital hemolytic disease (erythroblastosis fetalis); theoretic considerations.
    WIENER AS
    Am J Dis Child (1911); 1946 Jan; 71():14-24. PubMed ID: 21018125
    [No Abstract]   [Full Text] [Related]  

  • 3. Pathogenesis of congenital hemolytic disease (erythroblastosis fetalis); illustrative case histories of Rh sensitization.
    WIENER AS; SONN EB
    Am J Dis Child (1911); 1946 Jan; 71():25-40. PubMed ID: 21018126
    [No Abstract]   [Full Text] [Related]  

  • 4. Congenital hemolytic disease and erythroblastosis fetalis; two disease syndromes; a preliminary report.
    WIENER AS
    N Y State J Med; 1946 Apr; 46():912. PubMed ID: 21025880
    [No Abstract]   [Full Text] [Related]  

  • 5. Congenital hemolytic disease and erythroblastosis fetalis; two disease syndromes.
    WIENER AS
    J Parenter Ther; 1946; 2(2):12. PubMed ID: 20992262
    [No Abstract]   [Full Text] [Related]  

  • 6. Plan for management of erythroblastosis fetalis (congenital hemolytic disease) and icterus gravis neonatorum.
    RICKER W; CZAJKOWSKI JR
    Northwest Med; 1947 Aug; 46(8):620. PubMed ID: 20258043
    [No Abstract]   [Full Text] [Related]  

  • 7. Some notes on erythroblastosis fetalis.
    ROBELEN HC
    Clin Proc Child Hosp Dist Columbia; 1948 Mar; 4(4):93-100. PubMed ID: 18859432
    [No Abstract]   [Full Text] [Related]  

  • 8. Erythroblastosis fetalis. Notes on prognosis.
    CHOWN B
    J Lancet; 1951 Jun; 71(6):219-21. PubMed ID: 14841432
    [No Abstract]   [Full Text] [Related]  

  • 9. Erythroblastosis fetalis. I. Problems in the interpretation of changing mortality in erythroblastosis fetalis.
    VAUGHAN VC; ALLEN FH; DIAMOND LK
    Pediatrics; 1950 Aug; 6(2):173-82. PubMed ID: 14776002
    [No Abstract]   [Full Text] [Related]  

  • 10. Causes of death in infants with hemolytic disease of the newborn (erythroblastosis fetalis).
    VAN PRAAGH R
    Pediatrics; 1961 Aug; 28():223-33. PubMed ID: 13780037
    [No Abstract]   [Full Text] [Related]  

  • 11. Studies in erythroblastosis fetalis; investigations on the detection of sensitization of the red blood cells of newborn infants with erythroblastosis fetalis.
    WITEBSKY E; RUBIN MI
    J Lab Clin Med; 1947 Nov; 32(11):1339-49. PubMed ID: 18917893
    [No Abstract]   [Full Text] [Related]  

  • 12. Pathogenesis of erythroblastosis fetalis and the Shwartzman phenomenon.
    WIENER AS
    Exp Med Surg; 1949; 7(2-3):200-12. PubMed ID: 18151286
    [No Abstract]   [Full Text] [Related]  

  • 13. CLINICAL conference: the use of ACTH in hemolytic disease of the newborn (erythroblastosis fetalis).
    J Pediatr; 1951 Sep; 39(3):376-8. PubMed ID: 14881032
    [No Abstract]   [Full Text] [Related]  

  • 14. A case of erythroblastosis fetalis associated with congenital malformations, placental changes and renal disease in the mother.
    BISKIND LH; YOUNG AM
    Urol Cutaneous Rev; 1949 Jan; 53(1):10-2. PubMed ID: 18105805
    [No Abstract]   [Full Text] [Related]  

  • 15. [Erythroblastemia in the newborn; a morphological contribution to a differential diagnosis of erythroblastosis fetalis with special attention to the posthemorrhagic shock of the newborn].
    KOCH F; SCHLAGETTER K; SCHNEIDT W
    Monatsschr Kinderheilkd (1902); 1956 Jan; 104(1):11-21. PubMed ID: 13309236
    [No Abstract]   [Full Text] [Related]  

  • 16. A case of congenital sympathogonioma (neuroblastoma) of the right adrenal simulating erythroblastosis fetalis.
    FALKINBURG LW; KAY MN
    J Pediatr; 1953 Apr; 42(4):462-5. PubMed ID: 13053336
    [No Abstract]   [Full Text] [Related]  

  • 17. Management of erythroblastosis fetalis.
    BANNER EA; HARRIS LE; MATHIESON DR
    Med Clin North Am; 1956 Jul; 40(4):1033-43. PubMed ID: 13333405
    [No Abstract]   [Full Text] [Related]  

  • 18. Salicylates in the prevention of erythroblastosis fetalis.
    MCLENNAN CE; JAGER BV; MATSON GA
    Am J Med; 1947 Nov; 3(5):661. PubMed ID: 20269249
    [No Abstract]   [Full Text] [Related]  

  • 19. [Recent advances in blood group research, with special reference to the pathogenesis of erythroblastosis fetalis].
    van LOGHEM JJ
    Ned Tijdschr Geneeskd; 1951 Mar; 95(11):879-92. PubMed ID: 14833474
    [No Abstract]   [Full Text] [Related]  

  • 20. Determination of anti-Rh antibody in infants with erythroblastosis fetalis.
    WHEELER WE; SCHOLL ML
    Am J Dis Child (1911); 1947 Sep; 74(3):274-82. PubMed ID: 20267722
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.